Literature DB >> 22753196

Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a).

Houshang Nemati1, Reza Khodarahmi, Ameneh Rahmani, Ali Ebrahimi, Mojtaba Amani, Kamran Eftekhari.   

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by excessive cellular replication. Apolipoproteins are genetically determined molecule whose role has been implied in cardiovascular pathology. Vascular adhesion protein-1 (VAP-1) is an adhesion molecule with an enzymatic activity that partakes in the migration process of lymphocytes into sites of inflammation. Our purpose was to evaluate the plasma lipid profiles, apolipoproteins (A1, B) and Lp (a) and VAP-1 in order to compare the lipid profile in psoriatic patients with non-affected persons and correlation between VAP-1 and Lp (a). We determined serum concentrations of lipids, lipoproteins , apolipoproteins and VAP-1 in 90 patients with psoriasis and 90 age matched controls. Serum Lp (a), apo A1 and apo B were measured by immunoprecipitation assays, and the lipids and lipoproteins were measured by enzymatic methods.The VAP-1 were measured by ELISA method. The mean levels of total cholesterol, LDL, apo B and VAP-1 in patients with psoriasis were found to be significantly higher than those of healthy subjects (P<0.05. In psoriatic patients, elevation of VAP-1 correlated with elevation of Lp (a) (p = 0.025). This study shows that high serum lipid level and VAP-1, is significantly more common in psoriasis. This fact may be responsible for higher prevalence of cardiovascular accident in psoriatic patients.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753196     DOI: 10.1002/cbf.2857

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  4 in total

1.  Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.

Authors:  Can Wen; Jiao-Feng Lv; Ling Wang; Wei-Feng Zhu; Fu-Sheng Wan; Xiao-Zhong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

2.  Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients.

Authors:  Seraj Ahmed Khan; Sudha Agrawal; Nirmal Baral; Madhab Lamsal
Journal:  Psoriasis (Auckl)       Date:  2018-09-04

3.  Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies.

Authors:  Mazaher Ramezani; Elisa Zavattaro; Masoud Sadeghi
Journal:  Postepy Dermatol Alergol       Date:  2019-12-30       Impact factor: 1.837

4.  Current evidence on the role of lipid lowering drugs in the treatment of psoriasis.

Authors:  Jiao Wang; Shuo Zhang; Meng Xing; Seokgyeong Hong; Liu Liu; Xiao-Jie Ding; Xiao-Ying Sun; Ying Luo; Chun-Xiao Wang; Miao Zhang; Bin Li; Xin Li
Journal:  Front Med (Lausanne)       Date:  2022-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.